Royal Fund Management LLC Has $5.64 Million Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Royal Fund Management LLC reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 78.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 62,600 shares of the exchange traded fund’s stock after selling 233,886 shares during the period. Royal Fund Management LLC owned about 0.08% of SPDR S&P Biotech ETF worth $5,638,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of XBI. Tidemark LLC increased its stake in SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at about $40,000. ORG Wealth Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at about $44,000. Howe & Rusling Inc. bought a new stake in SPDR S&P Biotech ETF during the third quarter worth about $49,000. Finally, Waldron Private Wealth LLC acquired a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $54,000.

SPDR S&P Biotech ETF Stock Up 0.1 %

NYSEARCA:XBI opened at $87.97 on Tuesday. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The firm has a market capitalization of $6.71 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock’s 50 day moving average price is $93.78 and its two-hundred day moving average price is $96.96.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.